![Low‐Dose Aspirin for Primary Prevention of Cardiovascular Disease: Use Patterns and Impact Across Race and Ethnicity in the Southern Community Cohort Study | Journal of the American Heart Association Low‐Dose Aspirin for Primary Prevention of Cardiovascular Disease: Use Patterns and Impact Across Race and Ethnicity in the Southern Community Cohort Study | Journal of the American Heart Association](https://www.ahajournals.org/cms/asset/4860555a-015b-4db4-9336-0b7eb80d96a4/jah34577-fig-0001.png)
Low‐Dose Aspirin for Primary Prevention of Cardiovascular Disease: Use Patterns and Impact Across Race and Ethnicity in the Southern Community Cohort Study | Journal of the American Heart Association
![PDF] The Acute Stroke or Transient Ischemic Attack Treated with Ticagrelor and Aspirin for Prevention of Stroke and Death (THALES) trial: Rationale and design | Semantic Scholar PDF] The Acute Stroke or Transient Ischemic Attack Treated with Ticagrelor and Aspirin for Prevention of Stroke and Death (THALES) trial: Rationale and design | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/cfc35389ebc64406fddbc60b7c6a2d907ce71de1/3-Table1-1.png)
PDF] The Acute Stroke or Transient Ischemic Attack Treated with Ticagrelor and Aspirin for Prevention of Stroke and Death (THALES) trial: Rationale and design | Semantic Scholar
![Frontiers | Aspirin for Primary Stroke Prevention; Evidence for a Differential Effect in Men and Women Frontiers | Aspirin for Primary Stroke Prevention; Evidence for a Differential Effect in Men and Women](https://www.frontiersin.org/files/Articles/856239/fneur-13-856239-HTML-r1/image_m/fneur-13-856239-g001.jpg)
Frontiers | Aspirin for Primary Stroke Prevention; Evidence for a Differential Effect in Men and Women
![Dual Antiplatelet Therapy Using Cilostazol With Aspirin or Clopidogrel: Subanalysis of the CSPS.com Trial | Stroke Dual Antiplatelet Therapy Using Cilostazol With Aspirin or Clopidogrel: Subanalysis of the CSPS.com Trial | Stroke](https://www.ahajournals.org/cms/asset/6140a6d2-d67f-4167-afa6-8e74f3fe769f/strokeaha.121.034378.fig04.jpg)
Dual Antiplatelet Therapy Using Cilostazol With Aspirin or Clopidogrel: Subanalysis of the CSPS.com Trial | Stroke
![Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention | Nature Reviews Cardiology Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention | Nature Reviews Cardiology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41569-018-0049-1/MediaObjects/41569_2018_49_Fig1_HTML.jpg)
Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention | Nature Reviews Cardiology
![Dual Antiplatelet Therapy Versus Aspirin in Patients With Stroke or Transient Ischemic Attack: Meta-Analysis of Randomized Controlled Trials | Stroke Dual Antiplatelet Therapy Versus Aspirin in Patients With Stroke or Transient Ischemic Attack: Meta-Analysis of Randomized Controlled Trials | Stroke](https://www.ahajournals.org/cms/asset/8807f3f5-0f0d-403d-948a-a8e8aaff4bcc/strokeaha.120.033033.fig03.jpg)
Dual Antiplatelet Therapy Versus Aspirin in Patients With Stroke or Transient Ischemic Attack: Meta-Analysis of Randomized Controlled Trials | Stroke
![Time Course for Benefit and Risk of Ticagrelor and Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack | Neurology Time Course for Benefit and Risk of Ticagrelor and Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack | Neurology](https://n.neurology.org/sites/default/files/highwire/neurology/99/1/e46/embed/inline-graphic-1.gif)